Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-11-30FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) submitted by Alkermes, Inc. The approval involves modifications…
-
FDA approval · 2018-11-28FDA Approved: VRAYLAR — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for VRYALR (cariprazine) by Allergan, Inc., granting changes to the drug’s labeling.
-
FDA approval · 2018-11-19FDA Approved: OLANZAPINE — Original Application (HEC Pharm USA Inc.)
The FDA approved the original ANDA application for olanzapine, granting generic status to HEC Pharm USA Inc. for this antipsychotic drug.
-
FDA approval · 2018-11-05FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for GEODON (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2018-11-05FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-09-28FDA Approved: QUETIAPINE EXTENDED-RELEASE — Original Application (AlignScience Pharma Inc.)
FDA approved AlignScience Pharma Inc.'s generic extended-release quetiapine tablets (ANDA 209497). The approval enables a generic version of…
-
FDA approval · 2018-09-10FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved chlorpromazine hydrochloride under an original application from Amneal Pharmaceuticals; approved indications include schizophre…
-
FDA approval · 2018-07-27FDA Approved: PERSERIS — Original Application (Indivior Inc.)
The FDA approved Perseris (risperidone subcutaneous long-acting injectable) under its original NDA for adults with schizophrenia, introducin…
-
FDA approval · 2018-07-27FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved Janssen's supplemental application for RISPERDAL M-TAB (risperidone), resulting in updated labeling or expanded indications for…
-
FDA approval · 2018-07-03FDA Approved: HALOPERIDOL DECANOATE — Original Application (Somerset Therapeutics, LLC)
FDA approved haloperidol decanoate, a long-acting injectable antipsychotic, under an original application filed by Somerset Therapeutics, LL…
-
FDA approval · 2018-07-03FDA Approved: OLANZAPINE — Original Application (HEC Pharm USA Inc.)
FDA approved the original Abbreviated New Drug Application for olanzapine (generic) submitted by HEC Pharm USA Inc. The approval enables a g…
-
FDA approval · 2018-06-29FDA Approved: ARISTADA INITIO — Original Application (Alkermes, Inc.)
FDA approved ARISTADA INITIO (aripiprazole lauroxil) under an original application, establishing the initiating regimen for this long-acting…
-
FDA approval · 2018-06-08FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for HALOPERIDOL LACTATE from Fresenius Kabi USA, LLC, authorizing changes to the marketed halope…
-
FDA approval · 2018-04-18FDA Approved: ARIPIPRAZOLE — Original Application (Dr. Reddy's Laboratories Inc)
The FDA approved Dr. Reddy's Laboratories' generic aripiprazole orally disintegrating tablet through an original ANDA, enabling a generic ve…
-
FDA approval · 2018-04-09FDA Approved: CLOZAPINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's generic clozapine through an Original Application (ANDA) for Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2018-03-27FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2018-01-25FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
FDA approves a supplemental application for ARISTADA (aripiprazole lauroxil) submitted by Alkermes, Inc. The approval updates the drug's lab…
-
FDA approval · 2017-12-20FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2017-12-14FDA Approved: DROPERIDOL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a generic version of droperidol under an original application by Hikma Pharmaceuticals USA Inc. This approval adds another gene…
-
FDA approval · 2017-12-11FDA Approved: ARIPIPRAZOLE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma's ARIPIPRAZOLE as an original application generic, allowing marketing for the same indications as the reference prod…
-
FDA approval · 2017-12-05FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate from Patriot Pharmaceuticals LLC.
-
FDA approval · 2017-12-04FDA Approved: ARIPIPRAZOLE — Original Application (Solco Healthcare U.S., LLC)
FDA approved ARIPIPRAZOLE from Solco Healthcare U.S., LLC as an original generic application. The approval allows generic aripiprazole for t…
-
FDA approval · 2017-11-30FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic quetiapine under an Original Application (ANDA204253), making a generic version of q…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
FDA approved a generic quetiapine fumarate product from Accord Healthcare Inc. under an original ANDA.